Dentsply Sirona Inc (XRAY) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Dentsply Sirona Inc   (NASDAQ: XRAY)


Dentsply Sirona Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dentsply Sirona Inc's ROI in the second quarter of 2026?
Dentsply Sirona Inc recorded a cumulative net loss of $-547 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -13.47%.

Within the Healthcare sector 262 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1963 to 3197.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -11.77 % -9.52 % -15.13 % -22.17 % -21.58 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3,885 4,023 4,087 4,248 4,904
Return On Investment (TTM) -13.47 % -14.53 % -13.67 % -20.05 % -20.6 %
XRAY's Overall Ranking # 3197 # 1963 # 2007 # 2962 # 2695
Seq. Investment Change TTM -5.9 % -1.34 % -0.44 % -4.54 % -3.51 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -547 -627 -598 -881 -948




Return On Investment XRAY's Ranking
Within: No.
Industry # 82
Sector # 263
Overall # 3197

Return On Investment Statistics
High Average Low
43.95 %
0.65 %
-32.68 %
(Dec. 31, 2007)   (Sep 30 2018)



  News about Dentsply Sirona Inc Return on Investment ROI

Charting New Horizons: Dentsply Sirona's Quest for a Visionary CFO,

August 20, 2024

Dentsply Sirona Embarks on Quest to Find New CFO as Glenn Coleman Makes a Strategic Move to another Firm
In the ever-evolving corporate world, leadership changes often mark new beginnings, fresh strategies, and growth opportunities for companies across various industries. In a recent announcement, Dentsply Sirona, a leading manufacturer of dental products and technologies, disclosed the initiation of a search for a new Chief Financial Officer (CFO) as current CFO, Glenn Coleman, prepares to resign in November for an exciting career move into another company.
Glenn Coleman s departure from Dentsply Sirona signifies the end of a remarkable era, during which he contributed significantly to the financial success and overall strategic direction of the company. Coleman s expertise and dedication have proven instrumental in positioning Dentsply Sirona as a key player in the dental industry. His numerous achievements include spearheading strategic initiatives, effectively managing financial resources, and driving operational excellence.

Dentsply Sirona Faces Hurdles in Financial Performance and Conference Engagement, Aiming for Recuperation and Growth

June 12, 2024

Dentsply Sirona, a leading dental equipment manufacturer, recently provided an update regarding its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. Due to weather-related flight disruptions, the company has unfortunately been forced to cancel its involvement in this prestigious event. Originally scheduled for June 13, 2024, at 8:00 am ET, Dentsply Sirona s absence is undoubtedly disappointing for both the company and conference attendees.
In addition to this unforeseen setback, Dentsply Sirona has also reported a cumulative net loss of $-187 million during the 12-month period ending in the first quarter of 2024. This substantial loss has resulted in a negative return on investment (ROI) of -3.06%. These financial figures reflect a challenging time for the company, and it is important to assess their impact on Dentsply Sirona s future prospects and operations.






Financial Statements
Dentsply Sirona Inc's II. Quarter Investments $ 3,885 Millions XRAY's Balance sheet
Dentsply Sirona Inc's II. Quarter Income $ 36 Millions Quarterly XRAY's Income Statement
XRAY's Income by Division See XRAY's Income by Division


XRAY Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 4,087 4,165 6,130 6,474 7,979
Y / Y Investment Growth -1.87 % -32.06 % -5.31 % -18.86 % -10.17 %
Net Income in Millions -598 -910 -132 -950 411
Y / Y Net Income Growth - - - - -
Annual Return On Investment -14.63 % -21.85 % -2.15 % -14.67 % 5.15 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XRAY's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XRAY's Competitors
Subscribers only: Roi for Dentsply Sirona Inc's Suppliers
Subscribers only: Return On Investment for XRAY's Customers

Other Ratios
XRAY's Roa XRAY's Inventory Turnover Ratio XRAY's Growth Rates XRAY's Dividend Statistics
XRAY's Profitability Ratios XRAY's Asset Turnover Ratio XRAY's Dividend Growth
XRAY's Roe XRAY's Valuation Ratios XRAY's Financial Strength Ratios XRAY's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.